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 ABSTRACT 
 
The thesis entitled “computer-aided drug design approaches in developing anti-cancer drug” 
is divided into a total of six chapters. In the first chapter, an overview of drug discovery and 
development are introduced. The whole process of drug discovery and development is lengthy 
and complicated, which require huge input of time, money, and resources. Acknowledging 
that drug discovery is complicated in general, oncology has one of the poorest records for 
developing into clinical trial phases, however, we have moved into a new “golden era” for 
cancer drug development through molecular targeting recently. In the second chapter, 
computer-aided drug design (CADD), which is effective methods for facilitating and 
expediting drug discovery and development process, are introduced. Some approved drugs 
that credited their discovery in large part to the tools of CADD were reported, and the 
application of CADD has extended to two directions in drug discovery and development. In 
the third chapter, a detailed introduction of the anti-cancer targets in this thesis is given. The 
targets include tyrosine kinase RET, kinesin Eg5 and KIF18B, histone transferase Tip60 and 
the GTPase K-Ras. The involving signalling pathway, the cancer induced mechanism and the 
current available inhibitors for the targets are discussed. In the fourth chapter, the 
methodologies applied for different projects will be discussed, including homology modelling, 
docking, molecular dynamics simulations, structure-based pharmacophore, ligand-based 
pharmacophore and 3D-QSAR. The detailed theorectical background and the main steps 
involve in the use of these methods are outlined. In the fifth chapter, I provide a summary of 
seven papers or manuscripts, which are related to this thesis. In the final chapter, conclusions 
and future perspective is given, CADD is indeed a very useful tool for pharmaceutical 
companies and academic research groups to search for potential drug candidates, meanwhile, 
it is also necessary to improve the current CADD methods. The different projects included 
in this thesis have the potential for further development.  
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